Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 46 | 2023 | 807 | 9.020 |
Why?
|
Idiopathic Pulmonary Fibrosis | 20 | 2023 | 451 | 5.080 |
Why?
|
Pulmonary Fibrosis | 11 | 2023 | 526 | 2.670 |
Why?
|
Mucin-5B | 11 | 2023 | 141 | 2.450 |
Why?
|
Lung | 46 | 2023 | 9826 | 2.280 |
Why?
|
Respiratory System Abnormalities | 4 | 2023 | 69 | 2.020 |
Why?
|
Pulmonary Emphysema | 9 | 2021 | 672 | 1.770 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 15 | 2023 | 3038 | 1.310 |
Why?
|
Tomography, X-Ray Computed | 46 | 2023 | 20086 | 1.150 |
Why?
|
Asthma | 15 | 2011 | 5955 | 0.880 |
Why?
|
Polymorphism, Genetic | 5 | 2017 | 4328 | 0.860 |
Why?
|
Immunoglobulin E | 7 | 2011 | 1460 | 0.830 |
Why?
|
Respiratory Function Tests | 12 | 2021 | 1613 | 0.750 |
Why?
|
Smoking | 15 | 2023 | 8969 | 0.730 |
Why?
|
Hernia, Hiatal | 1 | 2020 | 79 | 0.710 |
Why?
|
Genetic Predisposition to Disease | 19 | 2023 | 17400 | 0.690 |
Why?
|
Emphysema | 1 | 2021 | 247 | 0.660 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2019 | 265 | 0.630 |
Why?
|
Promoter Regions, Genetic | 8 | 2019 | 5867 | 0.620 |
Why?
|
Polymorphism, Single Nucleotide | 18 | 2019 | 15494 | 0.610 |
Why?
|
Bronchiectasis | 3 | 2023 | 128 | 0.570 |
Why?
|
Spirometry | 7 | 2021 | 862 | 0.550 |
Why?
|
Forced Expiratory Volume | 7 | 2018 | 1741 | 0.500 |
Why?
|
Galectin 3 | 1 | 2016 | 227 | 0.490 |
Why?
|
Lung Diseases | 7 | 2023 | 1884 | 0.480 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 782 | 0.460 |
Why?
|
Disease Progression | 8 | 2023 | 13256 | 0.460 |
Why?
|
Costa Rica | 7 | 2010 | 177 | 0.440 |
Why?
|
Iceland | 4 | 2020 | 183 | 0.410 |
Why?
|
Sex Characteristics | 4 | 2015 | 2585 | 0.410 |
Why?
|
Lung Neoplasms | 8 | 2023 | 13019 | 0.410 |
Why?
|
Antifibrinolytic Agents | 1 | 2014 | 254 | 0.400 |
Why?
|
Pyroglyphidae | 2 | 2008 | 87 | 0.390 |
Why?
|
Receptors, Interleukin-17 | 1 | 2011 | 69 | 0.390 |
Why?
|
Humans | 119 | 2023 | 742088 | 0.380 |
Why?
|
Total Lung Capacity | 4 | 2015 | 143 | 0.370 |
Why?
|
Family | 4 | 2020 | 3144 | 0.370 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2009 | 49 | 0.360 |
Why?
|
Male | 82 | 2023 | 349538 | 0.360 |
Why?
|
Female | 85 | 2023 | 379592 | 0.340 |
Why?
|
Pyridones | 1 | 2014 | 712 | 0.340 |
Why?
|
Interleukin-13 | 2 | 2011 | 389 | 0.340 |
Why?
|
Cytokines | 4 | 2012 | 7317 | 0.330 |
Why?
|
Referral and Consultation | 1 | 2021 | 3527 | 0.320 |
Why?
|
Telomere | 3 | 2022 | 909 | 0.310 |
Why?
|
Antigens, Dermatophagoides | 1 | 2008 | 100 | 0.310 |
Why?
|
Aged | 44 | 2021 | 162944 | 0.310 |
Why?
|
Cockroaches | 1 | 2008 | 96 | 0.310 |
Why?
|
Malaria | 1 | 2017 | 1232 | 0.310 |
Why?
|
Genome-Wide Association Study | 13 | 2023 | 12220 | 0.310 |
Why?
|
Ascaris lumbricoides | 1 | 2007 | 11 | 0.300 |
Why?
|
Cohort Studies | 21 | 2022 | 40450 | 0.290 |
Why?
|
Middle Aged | 52 | 2023 | 213127 | 0.290 |
Why?
|
Carbon Monoxide | 3 | 2019 | 531 | 0.290 |
Why?
|
Pleura | 2 | 2017 | 235 | 0.270 |
Why?
|
Genetic Testing | 2 | 2021 | 3439 | 0.270 |
Why?
|
Indoles | 1 | 2014 | 1834 | 0.270 |
Why?
|
Asbestos | 2 | 2017 | 251 | 0.260 |
Why?
|
Bronchopulmonary Sequestration | 1 | 2005 | 42 | 0.260 |
Why?
|
Longitudinal Studies | 9 | 2021 | 13921 | 0.260 |
Why?
|
Logistic Models | 7 | 2019 | 13403 | 0.260 |
Why?
|
Hypersensitivity | 4 | 2011 | 1093 | 0.240 |
Why?
|
Hypersensitivity, Immediate | 1 | 2007 | 334 | 0.240 |
Why?
|
Allergens | 3 | 2008 | 1314 | 0.230 |
Why?
|
Enzyme Inhibitors | 1 | 2014 | 3800 | 0.220 |
Why?
|
Prevalence | 10 | 2023 | 15194 | 0.220 |
Why?
|
Eosinophilia | 1 | 2007 | 531 | 0.220 |
Why?
|
Aging | 2 | 2021 | 8626 | 0.220 |
Why?
|
Interleukin-10 | 1 | 2008 | 1200 | 0.210 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2016 | 8925 | 0.210 |
Why?
|
Phenotype | 5 | 2021 | 16331 | 0.200 |
Why?
|
Proportional Hazards Models | 8 | 2022 | 12344 | 0.200 |
Why?
|
Pulmonary Alveoli | 3 | 2019 | 675 | 0.200 |
Why?
|
Adrenal Cortex Hormones | 2 | 2009 | 1847 | 0.200 |
Why?
|
Age Factors | 7 | 2021 | 18355 | 0.200 |
Why?
|
Survival Rate | 6 | 2021 | 12773 | 0.190 |
Why?
|
Genotype | 7 | 2019 | 12946 | 0.190 |
Why?
|
Hypertension, Pulmonary | 2 | 2023 | 1527 | 0.190 |
Why?
|
TATA Box Binding Protein-Like Proteins | 1 | 2019 | 8 | 0.180 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 176 | 0.180 |
Why?
|
Aged, 80 and over | 17 | 2021 | 57683 | 0.180 |
Why?
|
Interleukin-18 | 2 | 2019 | 248 | 0.180 |
Why?
|
beta Karyopherins | 1 | 2019 | 47 | 0.180 |
Why?
|
COUP Transcription Factor II | 1 | 2019 | 18 | 0.180 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 1999 | 43 | 0.170 |
Why?
|
Pleural Diseases | 2 | 2017 | 139 | 0.170 |
Why?
|
Scleroderma, Systemic | 1 | 2023 | 313 | 0.170 |
Why?
|
Pseudomonas Infections | 1 | 2023 | 608 | 0.170 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2011 | 4379 | 0.170 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2019 | 42 | 0.170 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12242 | 0.160 |
Why?
|
Pulmonary Embolism | 2 | 2023 | 2370 | 0.160 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3695 | 0.160 |
Why?
|
Common Variable Immunodeficiency | 1 | 2019 | 93 | 0.160 |
Why?
|
Genetic Markers | 3 | 2019 | 2633 | 0.160 |
Why?
|
Incidental Findings | 2 | 2020 | 688 | 0.160 |
Why?
|
Linear Models | 3 | 2019 | 5948 | 0.160 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15108 | 0.160 |
Why?
|
Lung Transplantation | 3 | 2016 | 1155 | 0.160 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5522 | 0.150 |
Why?
|
Genes, Immediate-Early | 1 | 1998 | 101 | 0.150 |
Why?
|
Environmental Exposure | 4 | 2019 | 4231 | 0.150 |
Why?
|
Granuloma | 3 | 2019 | 315 | 0.150 |
Why?
|
Inflammasomes | 2 | 2012 | 493 | 0.150 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2019 | 210 | 0.150 |
Why?
|
Vital Capacity | 3 | 2017 | 922 | 0.140 |
Why?
|
Odds Ratio | 2 | 2021 | 9846 | 0.140 |
Why?
|
Administration, Inhalation | 3 | 2019 | 1104 | 0.140 |
Why?
|
Early Diagnosis | 1 | 2021 | 1184 | 0.140 |
Why?
|
ROC Curve | 3 | 2022 | 3528 | 0.140 |
Why?
|
Virus Activation | 1 | 1998 | 319 | 0.140 |
Why?
|
Fibrosis | 1 | 2023 | 2026 | 0.130 |
Why?
|
Acute Lung Injury | 3 | 2019 | 378 | 0.130 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1998 | 442 | 0.130 |
Why?
|
Dinoprostone | 1 | 1998 | 600 | 0.130 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39004 | 0.130 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 24 | 0.130 |
Why?
|
CLOCK Proteins | 1 | 2014 | 87 | 0.120 |
Why?
|
Lung Injury | 1 | 2019 | 436 | 0.120 |
Why?
|
Intensive Care Units | 4 | 2019 | 3679 | 0.120 |
Why?
|
Adult | 25 | 2023 | 213712 | 0.120 |
Why?
|
Bronchial Provocation Tests | 2 | 2011 | 227 | 0.120 |
Why?
|
Coronary Vessels | 1 | 2005 | 3099 | 0.120 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1335 | 0.120 |
Why?
|
Biopsy | 4 | 2019 | 6756 | 0.120 |
Why?
|
Case-Control Studies | 7 | 2020 | 21719 | 0.120 |
Why?
|
DNA | 2 | 2018 | 7289 | 0.110 |
Why?
|
Cytomegalovirus | 1 | 1998 | 730 | 0.110 |
Why?
|
Epidemiologic Studies | 2 | 2021 | 676 | 0.110 |
Why?
|
Prognosis | 9 | 2021 | 29010 | 0.110 |
Why?
|
Cause of Death | 3 | 2020 | 3571 | 0.110 |
Why?
|
Risk Factors | 14 | 2023 | 72145 | 0.110 |
Why?
|
Leukocyte Count | 5 | 2014 | 1583 | 0.110 |
Why?
|
Early Detection of Cancer | 3 | 2023 | 3070 | 0.110 |
Why?
|
Traction | 2 | 2023 | 106 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2019 | 1835 | 0.110 |
Why?
|
Alleles | 4 | 2017 | 6931 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 722 | 0.110 |
Why?
|
Bronchiolitis Obliterans | 1 | 2013 | 193 | 0.100 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 1993 | 365 | 0.100 |
Why?
|
STAT6 Transcription Factor | 1 | 2011 | 199 | 0.100 |
Why?
|
Child | 14 | 2010 | 77478 | 0.100 |
Why?
|
Transplantation | 1 | 2013 | 217 | 0.100 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2021 | 1341 | 0.100 |
Why?
|
Oxygen | 1 | 2023 | 4169 | 0.100 |
Why?
|
Dyspnea | 1 | 2019 | 1298 | 0.100 |
Why?
|
Retrospective Studies | 13 | 2023 | 77098 | 0.100 |
Why?
|
Absorptiometry, Photon | 1 | 2017 | 1726 | 0.100 |
Why?
|
Cysts | 1 | 2015 | 676 | 0.090 |
Why?
|
Thymus Gland | 1 | 2015 | 1264 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2572 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 1183 | 0.090 |
Why?
|
Severity of Illness Index | 8 | 2020 | 15530 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2014 | 5310 | 0.090 |
Why?
|
Receptors, IgE | 1 | 2011 | 389 | 0.090 |
Why?
|
Egg Proteins | 1 | 2009 | 58 | 0.090 |
Why?
|
Sex Factors | 4 | 2015 | 10392 | 0.090 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 43 | 0.090 |
Why?
|
Pedigree | 3 | 2021 | 4646 | 0.080 |
Why?
|
RNA, Messenger | 2 | 2014 | 13029 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2013 | 814 | 0.080 |
Why?
|
Heart Diseases | 1 | 2021 | 2789 | 0.080 |
Why?
|
Respiration, Artificial | 2 | 2017 | 2566 | 0.080 |
Why?
|
Radiography, Thoracic | 2 | 2017 | 1265 | 0.080 |
Why?
|
Vasculitis | 1 | 2012 | 521 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2019 | 9410 | 0.080 |
Why?
|
Bronchospirometry | 1 | 2007 | 10 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2019 | 3920 | 0.080 |
Why?
|
Sarcoidosis | 2 | 1986 | 503 | 0.080 |
Why?
|
Tissue Donors | 1 | 2016 | 2205 | 0.070 |
Why?
|
Pneumonia | 2 | 2019 | 2117 | 0.070 |
Why?
|
Exercise Tolerance | 1 | 2012 | 770 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12958 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3548 | 0.070 |
Why?
|
Bone Marrow | 2 | 2015 | 2941 | 0.070 |
Why?
|
Prospective Studies | 10 | 2023 | 53187 | 0.070 |
Why?
|
Respiratory Hypersensitivity | 1 | 2007 | 274 | 0.070 |
Why?
|
Air Pollution | 1 | 2019 | 2284 | 0.070 |
Why?
|
Eosinophils | 2 | 2009 | 953 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3306 | 0.070 |
Why?
|
Genetic Linkage | 2 | 2008 | 2422 | 0.070 |
Why?
|
Mass Screening | 1 | 2021 | 5238 | 0.060 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2009 | 628 | 0.060 |
Why?
|
Skin Tests | 1 | 2007 | 612 | 0.060 |
Why?
|
Fungi | 1 | 2007 | 327 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2008 | 644 | 0.060 |
Why?
|
Inhalation Exposure | 1 | 2007 | 443 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4030 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3526 | 0.060 |
Why?
|
Critical Illness | 2 | 2014 | 2665 | 0.060 |
Why?
|
Graft Rejection | 2 | 2016 | 4393 | 0.060 |
Why?
|
Uridine Triphosphate | 1 | 2023 | 26 | 0.060 |
Why?
|
Bronchodilator Agents | 1 | 2007 | 502 | 0.060 |
Why?
|
Drug Resistance | 1 | 2009 | 1608 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.060 |
Why?
|
Registries | 1 | 2019 | 8077 | 0.060 |
Why?
|
Circadian Rhythm | 1 | 2014 | 2623 | 0.050 |
Why?
|
Comorbidity | 4 | 2022 | 10372 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4229 | 0.050 |
Why?
|
Family Health | 1 | 2007 | 1282 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2023 | 19862 | 0.050 |
Why?
|
Caspase 1 | 2 | 2012 | 223 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 62966 | 0.050 |
Why?
|
Linkage Disequilibrium | 3 | 2011 | 1995 | 0.050 |
Why?
|
Animals | 12 | 2021 | 168561 | 0.050 |
Why?
|
Body Mass Index | 2 | 2015 | 12695 | 0.050 |
Why?
|
Drug Synergism | 2 | 2012 | 1791 | 0.050 |
Why?
|
Biopsy, Needle | 2 | 2019 | 1640 | 0.050 |
Why?
|
Adolescent | 10 | 2017 | 85649 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 24913 | 0.050 |
Why?
|
Molecular Epidemiology | 1 | 2022 | 468 | 0.050 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 314 | 0.040 |
Why?
|
Liver | 1 | 2015 | 7470 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2012 | 3455 | 0.040 |
Why?
|
Bronchoalveolar Lavage | 1 | 2019 | 120 | 0.040 |
Why?
|
Gene Expression | 2 | 2023 | 7790 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 5019 | 0.040 |
Why?
|
Methacholine Chloride | 2 | 2009 | 233 | 0.040 |
Why?
|
Monocytes | 3 | 2022 | 2593 | 0.040 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 1998 | 58 | 0.040 |
Why?
|
Occupations | 1 | 2020 | 517 | 0.040 |
Why?
|
Immunity, Cellular | 2 | 1986 | 1606 | 0.040 |
Why?
|
Carboxyhemoglobin | 1 | 2017 | 81 | 0.040 |
Why?
|
Asbestosis | 1 | 2017 | 82 | 0.040 |
Why?
|
Sampling Studies | 1 | 2019 | 623 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2023 | 865 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2021 | 546 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2130 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 480 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15244 | 0.040 |
Why?
|
Young Adult | 5 | 2017 | 56350 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3691 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3239 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2021 | 725 | 0.030 |
Why?
|
Ozone | 1 | 2019 | 469 | 0.030 |
Why?
|
MicroRNAs | 1 | 2012 | 3731 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2023 | 4440 | 0.030 |
Why?
|
Carbon | 1 | 2019 | 686 | 0.030 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2015 | 48 | 0.030 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 902 | 0.030 |
Why?
|
Incidence | 3 | 2023 | 20928 | 0.030 |
Why?
|
Cough | 1 | 2019 | 555 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14720 | 0.030 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2015 | 58 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 1986 | 10163 | 0.030 |
Why?
|
Vitamin D | 1 | 2009 | 3211 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1911 | 0.030 |
Why?
|
Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 30 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15056 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2015 | 402 | 0.030 |
Why?
|
United States | 6 | 2021 | 69693 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 528 | 0.030 |
Why?
|
Base Sequence | 2 | 2019 | 12797 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10248 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1002 | 0.030 |
Why?
|
Freund's Adjuvant | 1 | 1993 | 139 | 0.030 |
Why?
|
Hospitalization | 3 | 2021 | 10232 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2019 | 860 | 0.030 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1993 | 370 | 0.030 |
Why?
|
Sepsis | 2 | 2019 | 2589 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 552 | 0.030 |
Why?
|
alpha Karyopherins | 1 | 2012 | 41 | 0.030 |
Why?
|
Granulocytes | 1 | 2014 | 546 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2009 | 7873 | 0.030 |
Why?
|
Pneumonectomy | 1 | 2019 | 1093 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11363 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1525 | 0.030 |
Why?
|
Endotoxins | 1 | 2014 | 525 | 0.030 |
Why?
|
Mycobacterium | 1 | 1993 | 249 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6534 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1740 | 0.020 |
Why?
|
Genetic Variation | 2 | 2021 | 6540 | 0.020 |
Why?
|
Macrophages | 1 | 1986 | 5655 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1653 | 0.020 |
Why?
|
Chemokines | 1 | 2015 | 954 | 0.020 |
Why?
|
Spain | 1 | 2012 | 465 | 0.020 |
Why?
|
Observer Variation | 1 | 2017 | 2593 | 0.020 |
Why?
|
Bleomycin | 1 | 2012 | 499 | 0.020 |
Why?
|
Endotoxemia | 1 | 2012 | 206 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1707 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1827 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2107 | 0.020 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4664 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 1976 | 2236 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4211 | 0.020 |
Why?
|
Telomerase | 1 | 2015 | 729 | 0.020 |
Why?
|
Lymphocytes | 2 | 2014 | 2614 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 463 | 0.020 |
Why?
|
E-Selectin | 1 | 2012 | 579 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2012 | 766 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2017 | 12017 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6313 | 0.020 |
Why?
|
Transfection | 1 | 1998 | 5892 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 707 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2906 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2049 | 0.020 |
Why?
|
Bronchoconstrictor Agents | 1 | 2009 | 77 | 0.020 |
Why?
|
Mice | 6 | 2014 | 81045 | 0.020 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2012 | 273 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4030 | 0.020 |
Why?
|
Nedocromil | 1 | 2008 | 46 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3618 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2010 | 374 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 766 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 12071 | 0.020 |
Why?
|
Risk Assessment | 3 | 2020 | 23320 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 12730 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2018 | 2414 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3444 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 40054 | 0.020 |
Why?
|
Sex Ratio | 1 | 2008 | 110 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2187 | 0.020 |
Why?
|
Leukocytes | 2 | 2012 | 2039 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3862 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2009 | 438 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 7716 | 0.020 |
Why?
|
Particulate Matter | 1 | 2019 | 2523 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 939 | 0.020 |
Why?
|
Bronchial Hyperreactivity | 1 | 2008 | 319 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7141 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10943 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2012 | 712 | 0.020 |
Why?
|
Autoantibodies | 1 | 2015 | 2036 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2616 | 0.020 |
Why?
|
HLA Antigens | 1 | 2011 | 1382 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2014 | 2303 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2009 | 794 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7153 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2009 | 1547 | 0.020 |
Why?
|
Metabolomics | 1 | 2014 | 1467 | 0.020 |
Why?
|
Chemotactic Factors | 1 | 1986 | 199 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1661 | 0.020 |
Why?
|
Radiography | 1 | 2016 | 7010 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4771 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 2211 | 0.020 |
Why?
|
Walking | 1 | 2012 | 1177 | 0.020 |
Why?
|
Exercise Test | 1 | 2012 | 2075 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 2008 | 533 | 0.010 |
Why?
|
Genetics, Population | 1 | 2009 | 933 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9305 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8662 | 0.010 |
Why?
|
Neutrophils | 1 | 1976 | 3711 | 0.010 |
Why?
|
NF-kappa B | 1 | 2012 | 2500 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4214 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2781 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1999 | 9941 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 13853 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2010 | 1221 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 1999 | 7276 | 0.010 |
Why?
|
Interferons | 1 | 1986 | 704 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1986 | 1262 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6452 | 0.010 |
Why?
|
Exercise | 1 | 2018 | 5611 | 0.010 |
Why?
|
Methylprednisolone | 1 | 1983 | 388 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4187 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2012 | 2956 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2008 | 4742 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9735 | 0.010 |
Why?
|
Critical Care | 1 | 2012 | 2640 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2009 | 1788 | 0.010 |
Why?
|
Interleukin-2 | 1 | 1986 | 1887 | 0.010 |
Why?
|
Prednisone | 1 | 1983 | 1567 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 1979 | 300 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 3839 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1981 | 1866 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23387 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1976 | 329 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 18112 | 0.010 |
Why?
|
Lymphokines | 1 | 1979 | 949 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6454 | 0.010 |
Why?
|
Leukopenia | 1 | 1976 | 208 | 0.010 |
Why?
|
Genome, Human | 1 | 2008 | 4420 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15994 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2012 | 18006 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1976 | 1386 | 0.010 |
Why?
|
Research Design | 1 | 2010 | 5979 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 21821 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 1979 | 2513 | 0.010 |
Why?
|
Mutation | 1 | 2015 | 29717 | 0.010 |
Why?
|
Neoplasms | 1 | 2016 | 21596 | 0.000 |
Why?
|
Child, Preschool | 1 | 2008 | 40955 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1983 | 415 | 0.000 |
Why?
|
Administration, Oral | 1 | 1983 | 3913 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1983 | 6483 | 0.000 |
Why?
|